Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

250 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
High frequency of copy number alterations in myeloid leukaemia of Down syndrome.
Blink M, van den Heuvel-Eibrink MM, Aalbers AM, Balgobind BV, Hollink IH, Meijerink JP, van der Velden VH, Beverloo BH, de Haas V, Hasle H, Reinhardt D, Klusmann JH, Pieters R, Calado RT, Zwaan CM. Blink M, et al. Among authors: van den heuvel eibrink mm, van der velden vh. Br J Haematol. 2012 Sep;158(6):800-3. doi: 10.1111/j.1365-2141.2012.09224.x. Epub 2012 Jul 7. Br J Haematol. 2012. PMID: 22775985 Free article. No abstract available.
Low frequency of reverse transcription polymerase chain reaction-detectable chromosome aberrations in relapsed acute myeloid leukaemia: implications for detection of minimal residual disease.
van der Velden VH, Schoch C, Langerak AW, Schnittger S, Hoogeveen PG, van Dongen JJ. van der Velden VH, et al. Among authors: van dongen jj. Br J Haematol. 2001 Jun;113(4):1082-3. doi: 10.1046/j.1365-2141.2001.02821-7.x. Br J Haematol. 2001. PMID: 11442511 Free article. No abstract available.
Is there a relationship between in vitro drug resistance and level of minimal residual disease as detected by polymerase chain reaction at the end of induction therapy in childhood acute lymphoblastic leukaemia?
De Haas V, Kaspers GJ, Oosten L, Bresters D, Pieters R, Van Der Velden VH, Van Wering ER, Van Den Berg H, Van Der Schoot CE. De Haas V, et al. Among authors: van der velden vh, van den berg h, van der schoot ce, van wering er. Br J Haematol. 2002 Sep;118(4):1190-1. doi: 10.1046/j.1365-2141.2002.36211.x. Br J Haematol. 2002. PMID: 12199807 Free article. No abstract available.
Standardization of WT1 mRNA quantitation for minimal residual disease monitoring in childhood AML and implications of WT1 gene mutations: a European multicenter study.
Willasch AM, Gruhn B, Coliva T, Kalinova M, Schneider G, Kreyenberg H, Steinbach D, Weber G, Hollink IH, Zwaan CM, Biondi A, van der Velden VH, Reinhardt D, Cazzaniga G, Bader P, Trka J; European Study Group on WT1 Expression in Childhood AML. Willasch AM, et al. Among authors: van der velden vh. Leukemia. 2009 Aug;23(8):1472-9. doi: 10.1038/leu.2009.51. Epub 2009 Mar 26. Leukemia. 2009. PMID: 19322206
Long-term survival after significant treatment reduction in a patient with CBF-AML.
Driessen EM, van der Velden VH, Catsman-Berrevoets CE, van den Heuvel-Eibrink MM, Beishuizen A. Driessen EM, et al. Among authors: van der velden vh, van den heuvel eibrink mm. Pediatr Blood Cancer. 2011 Feb;56(2):325-6. doi: 10.1002/pbc.22854. Epub 2010 Nov 11. Pediatr Blood Cancer. 2011. PMID: 21157900 No abstract available.
Correct interpretation of T-ALL oncogene expression relies on normal human thymocyte subsets as reference material.
Larmonie NS, Dik WA, van der Velden VH, Hoogeveen PG, Beverloo HB, Meijerink JP, van Dongen JJ, Langerak AW. Larmonie NS, et al. Among authors: van der velden vh, van dongen jj. Br J Haematol. 2012 Apr;157(1):142-6. doi: 10.1111/j.1365-2141.2011.08926.x. Epub 2011 Nov 5. Br J Haematol. 2012. PMID: 22053714 Free article. No abstract available.
Human telomere disease due to disruption of the CCAAT box of the TERC promoter.
Aalbers AM, Kajigaya S, van den Heuvel-Eibrink MM, van der Velden VH, Calado RT, Young NS. Aalbers AM, et al. Among authors: van den heuvel eibrink mm, van der velden vh. Blood. 2012 Mar 29;119(13):3060-3. doi: 10.1182/blood-2011-10-383182. Epub 2012 Feb 8. Blood. 2012. PMID: 22323451 Free PMC article.
High GATA2 expression is a poor prognostic marker in pediatric acute myeloid leukemia.
Luesink M, Hollink IH, van der Velden VH, Knops RH, Boezeman JB, de Haas V, Trka J, Baruchel A, Reinhardt D, van der Reijden BA, van den Heuvel-Eibrink MM, Zwaan CM, Jansen JH. Luesink M, et al. Among authors: van der velden vh, van den heuvel eibrink mm, van der reijden ba. Blood. 2012 Sep 6;120(10):2064-75. doi: 10.1182/blood-2011-12-397083. Epub 2012 Jul 11. Blood. 2012. PMID: 22786876 Free article.
Absence of SBDS mutations in sporadic paediatric acute myeloid leukaemia.
Aalbers AM, Calado RT, Young NS, Zwaan CM, Kajigaya S, Baruchel A, Geleijns K, de Haas V, Kaspers GJ, Reinhardt D, Trka J, Kuijpers TW, Pieters R, van der Velden VH, van den Heuvel-Eibrink MM. Aalbers AM, et al. Among authors: van der velden vh, van den heuvel eibrink mm. Br J Haematol. 2013 Feb;160(4):559-61. doi: 10.1111/bjh.12134. Epub 2012 Nov 28. Br J Haematol. 2013. PMID: 23189942 Free PMC article. No abstract available.
250 results